Nutraceuticals and dietary supplements should not be used as pharmaceuticals to treat COVID-19.
作者信息
Chirumbolo Salvatore
机构信息
Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Italy.
出版信息
Nutrition. 2022 Jan;93:111494. doi: 10.1016/j.nut.2021.111494. Epub 2021 Sep 20.
Abstract
摘要
相似文献
1
Nutraceuticals and dietary supplements should not be used as pharmaceuticals to treat COVID-19.营养保健品和膳食补充剂不应作为治疗新冠肺炎的药物使用。
Nutrition. 2022 Jan;93:111494. doi: 10.1016/j.nut.2021.111494. Epub 2021 Sep 20.
2
Nutraceuticals - shedding light on the grey area between pharmaceuticals and food.营养保健品——揭示药品与食品之间的灰色地带。
Expert Rev Clin Pharmacol. 2018 Jun;11(6):545-547. doi: 10.1080/17512433.2018.1464911. Epub 2018 Apr 23.
3
Can nutraceuticals assist treatment and improve covid-19 symptoms?营养保健品能辅助治疗并改善新冠病毒感染症状吗？
Nat Prod Res. 2022 May;36(10):2672-2691. doi: 10.1080/14786419.2021.1914032. Epub 2021 May 5.
4
Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19.靶向包膜蛋白的药物和营养保健品的重新利用：一种对抗新冠病毒的可能治疗策略。
Genomics. 2021 Jan;113(1 Pt 2):1129-1140. doi: 10.1016/j.ygeno.2020.11.009. Epub 2020 Nov 13.
5
Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19.利用天然化合物作为对抗 COVID-19 的潜在治疗剂。
Curr Pharm Des. 2021;27(9):1144-1152. doi: 10.2174/1381612826666210101154118.
6
Prevention and treatment of upper respiratory diseases in the pandemic COVID-19 era.大流行 COVID-19 时代的上呼吸道疾病的预防和治疗。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1 Suppl. 2):3-8. doi: 10.23812/21-1supp2-2.
7
Immunomodulatory role and potential utility of various nutrients and dietary components in SARS-CoV-2 infection.各种营养素和膳食成分在新型冠状病毒感染中的免疫调节作用及潜在用途。
Int J Vitam Nutr Res. 2022 Jan;92(1):35-48. doi: 10.1024/0300-9831/a000715. Epub 2021 Jun 8.
8
Nutraceuticals and Pharmaceuticals from Marine Fish and Invertebrates.海洋鱼类和无脊椎动物的营养保健品和药品。
Mar Drugs. 2021 Jul 20;19(7):401. doi: 10.3390/md19070401.
9
Rebuttal to overinterpretation of the antiviral results for human coronavirus 229E relative to severe acute respiratory syndrome coronavirus-2 by Rowpar Pharmaceuticals.对Rowpar制药公司关于人冠状病毒229E相对于严重急性呼吸综合征冠状病毒2的抗病毒结果过度解读的反驳。
J Med Virol. 2021 Apr;93(4):1903-1904. doi: 10.1002/jmv.26762. Epub 2021 Jan 5.
10
Dietary supplements for the management of COVID-19 symptoms.用于管理 COVID-19 症状的膳食补充剂。
J Prev Med Hyg. 2022 Oct 17;63(2 Suppl 3):E221-E227. doi: 10.15167/2421-4248/jpmh2022.63.2S3.2764. eCollection 2022 Jun.
引用本文的文献
1
Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal.COVID-19 早期的家庭药物治疗以预防住院和降低死亡率：是时候提出一个合适的建议了。
Basic Clin Pharmacol Toxicol. 2022 Feb;130(2):225-239. doi: 10.1111/bcpt.13690. Epub 2021 Dec 2.
本文引用的文献
1
Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 Symptom Study app.新冠疫情期间膳食补充剂的适度效果：来自445850名新冠症状研究应用程序用户的见解
BMJ Nutr Prev Health. 2021 Apr 19;4(1):149-157. doi: 10.1136/bmjnph-2021-000250. eCollection 2021.
2
Dietary Supplements and Nutraceuticals under Investigation for COVID-19 Prevention and Treatment.正在接受新冠病毒预防和治疗研究的膳食补充剂与营养保健品
mSystems. 2021 May 4;6(3):e00122-21. doi: 10.1128/mSystems.00122-21.
3
Hesperetin's health potential: moving from preclinical to clinical evidence and bioavailability issues, to upcoming strategies to overcome current limitations.橙皮苷的健康潜力：从临床前证据到临床证据和生物利用度问题，再到即将出现的克服当前局限性的策略。
Crit Rev Food Sci Nutr. 2022;62(16):4449-4464. doi: 10.1080/10408398.2021.1875979. Epub 2021 Jan 25.
4
Potential use of polyphenols in the battle against COVID-19.多酚类物质在抗击新冠疫情中的潜在用途。
Curr Opin Food Sci. 2020 Apr;32:149-155. doi: 10.1016/j.cofs.2020.08.004. Epub 2020 Sep 9.
5
Acute and sub-chronic oral toxicity studies of hesperidin isolated from orange peel extract in Sprague Dawley rats.从陈皮提取物中分离得到的橙皮苷的急性和亚慢性经口毒性研究。
Regul Toxicol Pharmacol. 2019 Jul;105:77-85. doi: 10.1016/j.yrtph.2019.04.001. Epub 2019 Apr 13.
Zotero 插件